文献速递腹部乳腺CTMR

乳腺癌肝转移假性肝硬化的临床与影像特征分析

Analysis of clinical and imaging characteristics of pseudocirrhosis in breast cancer liver metastasis.
PubMed 文献 · Eur J Radiol · 2025-02-20

该回顾性研究纳入浙江大学附属第一医院2012年11月至2024年1月病理确诊乳腺癌肝转移患者,假性肝硬化组32例、对照组28例,分析临床资料及CT/MRI图像。结果显示假性肝硬化多发生于化疗或联合治疗后,早期肝脏合成功能似未受显著影响,肝包膜回缩、腹水、脾大、胃底静脉曲张等门脉高压征象可出现在假性肝硬化组,而对照组无门脉高压征象。

要点

  • 乳腺癌肝转移患者化疗或联合治疗后出现肝包膜回缩、腹水、脾大等门脉高压征象时需警惕假性肝硬化。
  • 假性肝硬化组肝包膜回缩以弥漫性(43.7%)和广泛性(31.3%)为主,局限性占25.0%。
  • 假性肝硬化早期肝脏合成功能似未受显著影响,PT正常占65.6%、白蛋白正常占58.3%、胆碱酯酶正常占95.8%。

核心结论

  • 化疗或联合治疗可能是乳腺癌肝转移患者发生假性肝硬化的触发因素,假性肝硬化早期肝脏合成功能似乎未受显著影响。

研究设计与样本

  • 回顾性分析浙江大学附属第一医院2012年11月至2024年1月病理确诊乳腺癌肝转移患者,假性肝硬化组32例(CT 27例、常规MRI 23例),对照组28例(CT 24例、常规MRI 20例),均为女性,假性肝硬化组平均年龄58.3±8.3岁,对照组56.5±7.8岁。

关键影像表现/征象

  • 两组肝转移灶均为多发、圆形,增强后表现为中度至明显环形或结节状强化。
  • 假性肝硬化组门静脉增粗2例(6.3%)、腹水18例(56.3%)、脾大11例(34.4%)、胃底静脉曲张3例(9.4%)。
  • 假性肝硬化组肝包膜回缩分类为弥漫性14例(43.7%)、广泛性10例(31.3%)、局限性8例(25.0%)。
  • 除转移瘤外,两组均未见异常结节。
  • 对照组未见门脉高压或其失代偿表现。

诊断标准与关键数值

  • 假性肝硬化组32例中,1例初诊时即出现多发肝转移并发展至假性肝硬化,其余31例在化疗或联合治疗后出现假性肝硬化。
  • 假性肝硬化组有实验室资料者24例,PT正常21例(65.6%)、延长3例(9.4%);白蛋白正常14例(58.3%)、降低10例(41.3%);胆碱酯酶正常23例(95.8%)、降低1例(4.2%)。
  • 对照组有实验室资料者26例,白蛋白正常18例(69.2%)、降低8例(30.8%);PT正常24例(92.3%)、延长2例(7.7%);胆碱酯酶正常27例(96.4%)、降低1例(3.6%)。

临床应用与阅片要点

  • 对乳腺癌肝转移患者化疗或联合治疗后随访时,应关注肝包膜回缩、腹水、脾大、胃底静脉曲张等门脉高压征象,以早期识别假性肝硬化。
  • 假性肝硬化早期肝脏合成功能似未显著受损,PT、白蛋白、胆碱酯酶可正常,阅片时不应仅凭实验室指标正常而排除假性肝硬化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Pseudocirrhosis that may be triggered by the treatment of breast cancer liver metastasis often begins insidiously and progresses rapidly. This complicates the accurate assessment of tumor growth or regression. Without timely intervention, patients are at significant risk of death due to acute liver failure or bleeding from ruptured varices.

OBJECTIVE: This study aims to explore the clinical and radiological characteristics of pseudocirrhosis, providing a theoretical basis for clinicians to facilitate early diagnosis and treatment, thereby reducing the misdiagnosis rate and mortality associated with this condition.

METHODS: This study conducted a retrospective analysis of clinical data and CT and MRI images from 32 patients (the pseudocirrhosis group) with pathologically confirmed breast cancer liver metastasis and radiological features of pseudocirrhosis, and 28 patients (the control group) with breast cancer liver metastasis without pseudocirrhosis, at the First Affiliated Hospital of Zhejiang University from November 2012 to January 2024. All patients were female, with an average age of 58.3 ± 8.3 years in the pseudocirrhosis group and 56.5 ± 7.8 years in the control group. In the pseudocirrhosis group, 27 patients underwent CT scans and 23 underwent routine MRI examinations. In the control group, 24 patients underwent CT scans and 20 underwent routine MRI examinations. Image analysis included the number of lesions, morphology, enhancement patterns, degree of liver capsule retraction, presence of portal hypertension, gastric varices, ascites, and abnormal nodules, as well as an analysis of patients' chemotherapy regimens, prothrombin time (PT), albumin, and cholinesterase levels.

RESULTS: In our study, liver metastases in both the pseudocirrhosis group and the control group were multiple and round-shaped, with enhanced lesions exhibiting moderate to marked ring or nodular enhancement. Among the 32 cases in the pseudocirrhosis group, one patient presented with multiple liver metastases and the development of pseudocirrhosis at initial diagnosis, while the remaining 31 patients developed pseudocirrhosis following chemotherapy or combined therapy. No abnormal nodules, were observed in either group aside from the metastatic tumors. In the pseudocirrhosis group, portal vein thickening was observed in 2 cases (6.3 %), ascites in 18 cases (56.3 %), splenomegaly in 11 cases (34.4 %), and gastric varices in 3 cases (9.4 %). The liver capsule retraction was classified as diffuse in 14 cases (43.7 %), extensive in 10 cases (31.3 %), and limited in 8 cases (25.0 %). Among the 24 patients with available laboratory data, the prothrombin time (PT) was normal in 21 cases (65.6 %) and prolonged in 3 cases (9.4 %), albumin levels were normal in 14 cases (58.3 %) and decreased in 10 cases (41.3 %), and cholinesterase levels were normal in 23 cases (95.8 %) with a decrease in 1 case (4.2 %). The control group showed no signs of portal hypertension or its decompensated manifestations; among the 26 patients with available data, albumin levels were normal in 18 cases (69.2 %) and decreased in 8 cases (30.8 %); PT was normal in 24 cases (92.3 %) and prolonged in 2 cases (7.7 %); cholinesterase levels were normal in 27 cases (96.4 %) with a decrease in 1 case (3.6 %).

CONCLUSION: Chemotherapy or combined therapy may be a triggering factor for the development of pseudocirrhosis in patients with breast cancer liver metastasis. In the early stages of pseudocirrhosis, liver synthetic function does not appear to be significantly affected.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Deng L, Lin S, Chen Y, et al. Analysis of clinical and imaging characteristics of pseudocirrhosis in breast cancer liver metastasis. Eur J Radiol. 2025. PMID: 40022838. doi:10.1016/j.ejrad.2025.112008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。